Second COVID-19 Vaccine Undergoes ‘Rolling Review’ By EMA

The European Medicines Agency is fast-tracking its review of the vaccine that BioNTech and Pfizer are developing and testing in Phase III trials.

Injection
COVID-19: the BNT162b2 vaccine is being tested in a global Phase III study • Source: Shutterstock

The European Medicines Agency has started a second rolling review of a COVID-19 vaccine – this time for BNT162b2, which BioNTech is developing in collaboration with Pfizer.

The EMA said on 6 October that its human medicines committee (the CHMP) has started evaluating the first batch of...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Review Pathways

More from Pathways & Standards